AU2001261518A1 - Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor - Google Patents

Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor

Info

Publication number
AU2001261518A1
AU2001261518A1 AU2001261518A AU6151801A AU2001261518A1 AU 2001261518 A1 AU2001261518 A1 AU 2001261518A1 AU 2001261518 A AU2001261518 A AU 2001261518A AU 6151801 A AU6151801 A AU 6151801A AU 2001261518 A1 AU2001261518 A1 AU 2001261518A1
Authority
AU
Australia
Prior art keywords
ant
production
screening assays
novel
adenine nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261518A
Other languages
English (en)
Inventor
Christen M. Anderson
Amy K. Carroll
William Clevenger
Robert E. Davis
Soumitra S. Ghosh
Scott W. Miller
Walter H. Moos
Yazhong Pei
Tomas R. Szabo
Sandra Eileen Wiley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Migenix Corp
Original Assignee
Mitokor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitokor Inc filed Critical Mitokor Inc
Publication of AU2001261518A1 publication Critical patent/AU2001261518A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001261518A 2000-05-11 2001-05-11 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor Abandoned AU2001261518A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56932700A 2000-05-11 2000-05-11
US09/569,327 2000-05-11
PCT/US2001/015416 WO2001085944A2 (en) 2000-05-11 2001-05-11 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor

Publications (1)

Publication Number Publication Date
AU2001261518A1 true AU2001261518A1 (en) 2001-11-20

Family

ID=24274963

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261518A Abandoned AU2001261518A1 (en) 2000-05-11 2001-05-11 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor

Country Status (5)

Country Link
EP (2) EP1283884A2 (enExample)
JP (1) JP2003532420A (enExample)
AU (1) AU2001261518A1 (enExample)
CA (1) CA2407886A1 (enExample)
WO (1) WO2001085944A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0328048D0 (en) * 2003-12-04 2004-01-07 Univ Sheffield Gene screen
JP2011521941A (ja) * 2008-05-30 2011-07-28 ミトロジクス Ａｎｔ−リガンド分子および生物学的アプリケ−ション
WO2010006476A1 (zh) * 2008-07-15 2010-01-21 大连珍奥药业有限公司 心肌肽、其制备方法及用途
CN104678031B (zh) * 2015-01-23 2016-05-04 四川省中医药科学院 高效液相色谱法检测苍术苷和/或羧基苍术苷的方法
CN116593431B (zh) * 2023-04-09 2025-11-07 湖南科技大学三亚研究院 一种基于亲和传感器法的米酵菌酸毒素便携式检测装置及检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE60803T1 (de) * 1983-06-27 1991-02-15 Genentech Inc Uebertragbare induzierbare kontrollsysteme, diese enthaltende expressionsvektoren, mit diesen transformierte mikroorganismen und ihre verwendung bei der expression von exogenem protein.
DE69122016T2 (de) * 1990-09-26 1997-04-30 Sumitomo Chemical Co Mitochondriales P450
US5656495A (en) * 1995-01-20 1997-08-12 Bristol-Myers Squibb Company Expression vector for human topoisomerase I
US5859215A (en) * 1995-10-25 1999-01-12 Wallac Oy Biospecific binding reactants labelled with luminescent lanthanide chelates and their use
WO1998019714A1 (en) * 1996-11-01 1998-05-14 Emory University Mouse lacking heart-muscle adenine nucleotide translocator protein and methods
DE19653498C1 (de) * 1996-12-20 1998-07-23 Wolf M Prof Dr Bertling Klonierungsvektor-System mit Fusionssequenz
US20030044776A1 (en) * 1998-09-25 2003-03-06 James A. Dykens Compositions and methods for identifying agents that alter mitochondrial permeability transition pores
EP1049780A1 (en) * 1998-11-03 2000-11-08 Mitokor Adenine nucleotide translocator (ant) fusion proteins and uses thereof
JP2003504035A (ja) * 1999-06-30 2003-02-04 クノール・ゲー・エム・ベー・ハー スクリーニング方法
US6562563B1 (en) * 1999-11-03 2003-05-13 Mitokor Compositions and mehtods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions

Also Published As

Publication number Publication date
CA2407886A1 (en) 2001-11-15
EP1783221A1 (en) 2007-05-09
WO2001085944A3 (en) 2002-08-29
JP2003532420A (ja) 2003-11-05
EP1283884A2 (en) 2003-02-19
WO2001085944A2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU2001286643A1 (en) Gene discovery using microarrays
AU2001279134A1 (en) Nucleotide incorporating enzymes
AU2001238030A1 (en) Detection of single nucleotide polymorphisms
AU4518601A (en) Microarray hybridization chamber
AU2001273548A1 (en) Photoselection of nucleic acid ligands
AU2925600A (en) Genetic screening
AU2002237729A1 (en) Process for the production of polycarbonate
AU3572799A (en) Function-based gene discovery
AU2002352353A1 (en) Process for production of styrene
AU2002232923A1 (en) A one-well assay for high throughput detection of single nucleotide polymorphisms
AU2002339707A1 (en) Genetic screening methods
AU6387000A (en) Serial analysis of genetic alterations
AUPQ398399A0 (en) Improvements relating to screening of guttering
AU2001265935A1 (en) Production of biohydrolysates
AU2001292236A1 (en) 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
AU2001285842A1 (en) Assay for screening compounds for inducing drug metabolizing enzymes
AUPR805101A0 (en) A method of genetic screening using an amplifiable gene
AU3005500A (en) Methods of screening for antiviral compounds
AU2002324856A1 (en) High throughput screening assays using fatty acid synthetic enzymes
AU9223601A (en) 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
AU2001264931A1 (en) High-throughput purification process
AU3820599A (en) Production of ziegler-natta catalysts
AU1720501A (en) Methods of producing novel enzymes
WO2001085944A3 (en) Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
AU7275100A (en) Vegetal peptones for dna production